FDA Adverse Event Malfunction Summary report: N

ANGIOJET® ZELANTEDVT¿

MDR report key: 6101531 · Received November 15, 2016

Doing adverse event research by hand?

The Research Assistant searches MAUDE for you, groups reports by failure mode, and cites every record.

Free to try · every answer cites its records

Report

Report Number
2134265-2016-10449
Event Type
Malfunction
Date Received
November 15, 2016
Date of Event
October 17, 2016
Report Date
October 17, 2016
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
DXE
PMA / PMN Number
K151313
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DEVICE EVALUATED BY MANUFACTURER: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE MOST PROBABLE ROOT CAUSE IS OPERATIONAL CONTEXT AS DEVICE PERFORMANCE WAS LIMITED DUE TO ANATOMICAL PROCEDURAL FACTORS. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING ASPIRATION AN ERROR MESSAGE OCCURRED AND STOPPED THE CONSOLE. A THROMBECTOMY PROCEDURE WAS BEING PERFORMED IN THE ILIOFEMORAL VEIN WITH THE USE OF AN ANGIOJET® ZELANTEDVT" CATHETER AND AN ANGIOJET® ULTRA SYSTEM CONSOLE. THE CATHETER WAS PRIMED ADVANCED INTO THE PATIENT AND ASPIRATION WAS STARTED. AFTER A SHORT PERIOD OF USE, AN ERROR CODE OCCURRED AND THE CONSOLE STOPPED WORKING. A FLUID LEAK WAS NOTICED FROM THE CATHETER PUMP WHICH IS LOCATED INSIDE THE CONSOLE. THE CATHETER WAS REMOVED FROM THE PATIENT AND EXCHANGED FOR AN ANGIOJET SOLENT CATHETER TO COMPLETE THE PROCEDURE WITHOUT POST PROCEDURAL PATIENT COMPLICATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
753529 ANGIOJET® ZELANTEDVT¿ CATHETER, EMBOLECTOMY DXE BOSTON SCIENTIFIC - MAPLE GROVE 114610-001 19609760

Patients

Seq Age Sex Outcome Treatment
1